Aarti Pharmalabs Limited
NSE: AARTIPHARM.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hetal Gogri Gala
- Employees
- 2,095
- Headquarters
- Mumbai, India
- IPO year
- 2023
- Market cap
- ₹69.5B
- Website
- https://www.aartipharmalabs.com
Loading AARTIPHARM…
Loading profile data…Frequently asked questions about AARTIPHARM
What does Aarti Pharmalabs Limited (AARTIPHARM.NS) do?
Aarti Pharmalabs Limited manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, new chemical entities, and xanthine derivatives in India. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is based in Mumbai, India.
Where does AARTIPHARM.NS trade?
Aarti Pharmalabs Limited (AARTIPHARM.NS) trades on the National Stock Exchange of India.
What sector is AARTIPHARM.NS in?
Aarti Pharmalabs Limited (AARTIPHARM.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Aarti Pharmalabs Limited?
Hetal Gogri Gala is the chief executive officer of Aarti Pharmalabs Limited (AARTIPHARM.NS).
Where is Aarti Pharmalabs Limited headquartered?
Aarti Pharmalabs Limited is headquartered in India.
Does AARTIPHARM.NS pay a dividend?
Yes — Aarti Pharmalabs Limited (AARTIPHARM.NS) paid a trailing twelve-month dividend of INR 4.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did AARTIPHARM.NS go public?
Aarti Pharmalabs Limited (AARTIPHARM.NS) completed its initial public offering in 2023.